Xencor is a clinical stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer.
Social Media Links
REPORT RATINGS
4.8 / 5.0 (178)
Xencor Inc reports have an aggregate usefulness score of 4.8 based on 178 reviews.